Literature DB >> 3290485

Conformationally constrained renin inhibitory peptides: gamma-lactam-bridged dipeptide isostere as conformational restriction.

S Thaisrivongs1, D T Pals, S R Turner, L T Kroll.   

Abstract

A model of the conformation of the enzyme-bound inhibitor of human renin suggested the possibility of a gamma-lactam conformational restriction at the P2-P3 site. Synthetic routes to these gamma-lactam dipeptide isosteres and their incorporation into potential renin inhibitors are described. Peptide VIa,b with a gamma-lactam conformational constraint and a hydroxyethylene isostere at the cleavage site inhibited human plasma renin with an IC50 value of 6.5 nM. The flexibility of these syntheses should make available a number of potential enzyme inhibitors with this structural feature for the study of enzyme-bound conformers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290485     DOI: 10.1021/jm00402a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.

Authors:  V J Hruby; F al-Obeidi; W Kazmierski
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

2.  The conformational preferences of gamma-lactam and its role in constraining peptide structure.

Authors:  P K Paul; P A Burney; M M Campbell; D J Osguthorpe
Journal:  J Comput Aided Mol Des       Date:  1990-09       Impact factor: 3.686

3.  Short stereoselective synthesis of alpha-substituted gamma-lactams.

Authors:  Bhooma Raghavan; Rodney L Johnson
Journal:  J Org Chem       Date:  2006-03-03       Impact factor: 4.354

4.  Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.

Authors:  Xiongyu Wu; Per Ohrngren; Advait A Joshi; Alejandro Trejos; Magnus Persson; Riina K Arvela; Hans Wallberg; Lotta Vrang; Asa Rosenquist; Bertil B Samuelsson; Johan Unge; Mats Larhed
Journal:  J Med Chem       Date:  2012-03-13       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.